Smarter Team

About the Author Smarter Team

Smarter Analyst was established to fill a gap in financial reporting for sell-side investors, where they can read exclusive reports in real time. Smarter Analyst provides coverage of equities research, unique analyst insights, and outstanding articles from knowledgeable contributors, in addition to the latest stock market news, all hand-picked by our editors.

All Eyes On Advanced Micro Devices, Inc. (AMD); Wall Street Analysts Exchange Thoughts Ahead Of Earnings

Short-Term Performance Is Raring for an Outclass: Susquehanna  Susquehanna analyst Christopher Rolland is so confident on Advanced Micro Devices, Inc. (NASDAQ:AMD) ahead of the chip giant’s …

All Eyes on AcelRx Pharmaceuticals Inc (ACRX) Ahead of FDA Decision

A heavy-hitter catalyst is about to go up to bat for AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a key FDA decision looming in the foreground, …

Helios and Matheson Analytics Inc (HMNY) Investors Like Their Movie Passes Against Citron Research’s Bearish Prediction

Helios and Matheson Analytics Inc (NASDAQ:HMNY) investors are deciding they want to play with fire, or at least that is how infamous short-seller …

Unemployment: More Complicated Than Clear

Everyone knows that being out of work is terrible. The financial and, consequently, personal impact of being without a job reaches farther than …

Veritone Inc (VERI): Roth Capital VS. Citron Research

There’s more than meets the eye when it comes to Veritone, says Brian Alger in response to Citron’s comments.

Genocea Biosciences Inc (GNCA) Investors Run for the Hills; Here’s Why

Genocea shares are plunging on termination of genital herpes treatment GEN-003.

A Glimpse Into the Biotech Sector: Intercept Pharmaceuticals Inc (ICPT), IntelliPharmaCeutics Intl Inc (USA) (IPCI)

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) management hosted a conference call this morning to address Ocaliva safety concerns. As a reminder, company issued a Healthcare …

The Current State of the UK Economy and How to Tackle the Challenges

According to leading financial authorities, the economy of the United Kingdom is in dire shape. If UBS is correct, then economic stagnation faces …

Otonomy Inc (OTIC): What’s Left After Otividex Disappointment?

Edward Nash Sees Otonomy as a Pure Speculative Pharma Play

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts